On ECHEMI
Home > Drugs > sarcoma
sarcoma
Malignant tumors originating from mesenchymal tissue (including connective tissue and muscle) are called "sarcomas". They often occur in the skin, subcutaneous tissue, periosteum and both ends of long bones. For example, fibrosarcoma grows rapidly, and in the late stage of the tumor, there is often necrosis and bleeding. The cross-section is gray-red and the texture is uniform and fine like raw fish meat. Osteosarcoma is more common in young people and is prone to occur at the ends of the long bones of the limbs, especially the lower end of the femur, the upper end of the tibia and the upper end of the humerus. Osteosarcoma develops rapidly and has a short course of disease. It starts to grow in the cortex and can gradually develop into the bone marrow cavity. Sometimes it breaks through the periosteum and invades the surrounding soft tissue, which can easily cause pathological fractures. Other common ones include leiomyoma, lymphosarcoma, synovial sarcoma, etc. Hematogenous metastasis can occur in the early stage. Sarcoma is a malignant tumor lesion.
  • Site of disease:

    Skin whole body
  • Infectious :

    Not contagious
  • Frequent population:

    How common is it in adults
  • Related symptoms:

    Low fever Low fever fatigue Joint pain Limb pain Nodules
  • Concurrent disease:

Related Drugs
Cyclophosphamide
Indication: Cyclophosphamide is one of the most widely used anticancer drugs. It has significant effects in treating malignant lymphoma, multiple myeloma, breast cancer, small cell lung cancer, ovarian cancer, neuroblastoma, retinoblastoma, Ewing's tumor, soft tissue sarcoma, acute leukemia and chronic lymphocytic leukemia. Currently, cyclophosphamide is often used in clinical treatment in combination with other anticancer drugs. This drug is also used as an immunosuppressant to treat non-tumor diseases.
Manufacturer:

Bei Jing Scrianen Pharmaceutical Co., Ltd.

Cyclophosphamide
Indication: Cyclophosphamide is one of the most widely used anticancer drugs. It has significant effects in treating malignant lymphoma, multiple myeloma, breast cancer, small cell lung cancer, ovarian cancer, neuroblastoma, retinoblastoma, Ewing's tumor, soft tissue sarcoma, acute leukemia and chronic lymphocytic leukemia. Currently, cyclophosphamide is often used in clinical treatment in combination with other anticancer drugs. This drug is also used as an immunosuppressant to treat non-tumor diseases.
Cyclophosphamide
Indication: Cyclophosphamide is one of the most widely used anticancer drugs. It has significant effects in treating malignant lymphoma, multiple myeloma, breast cancer, small cell lung cancer, ovarian cancer, neuroblastoma, retinoblastoma, Ewing's tumor, soft tissue sarcoma, acute leukemia and chronic lymphocytic leukemia. Currently, cyclophosphamide is often used in clinical treatment in combination with other anticancer drugs. This drug is also used as an immunosuppressant to treat non-tumor diseases.
Manufacturer:

Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd.

Cyclophosphamide
Indication: Cyclophosphamide is one of the most widely used anticancer drugs. It has significant effects in treating malignant lymphoma, multiple myeloma, breast cancer, small cell lung cancer, ovarian cancer, neuroblastoma, retinoblastoma, Ewing's tumor, soft tissue sarcoma, acute leukemia and chronic lymphocytic leukemia. Currently, cyclophosphamide is often used in clinical treatment in combination with other anticancer drugs. This drug is also used as an immunosuppressant to treat non-tumor diseases.
Manufacturer:

Shanxi PUDE Pharmaceutical Co., Ltd.

Cyclophosphamide
Indication: Cyclophosphamide is one of the most widely used anticancer drugs. It has significant effects in treating malignant lymphoma, multiple myeloma, breast cancer, small cell lung cancer, ovarian cancer, neuroblastoma, retinoblastoma, Ewing's tumor, soft tissue sarcoma, acute leukemia and chronic lymphocytic leukemia. Currently, cyclophosphamide is often used in clinical treatment in combination with other anticancer drugs. This drug is also used as an immunosuppressant to treat non-tumor diseases.
Manufacturer:

Zhejiang Hisun Pharmaceutical Co., Ltd.

Methotrexate
Indication: 1. Systemic medication for the treatment of choriocarcinoma, malignant hydatidiform mole, various acute leukemias with breast cancer, lung cancer, head and neck cancer, digestive tract cancer, cervical cancer and malignant lymphoma. 2. Arterial catheter perfusion has a good effect on head and neck cancer and liver cancer. 3. High-dose methotrexate supplemented with calcium folinate rescue (HDMTX-CFR therapy) has a certain effect as postoperative adjuvant chemotherapy or systemic treatment of advanced lesions for osteosarcoma, soft tissue sarcoma, malignant lymphoma, acute lymphocytic leukemia with breast cancer, ovarian cancer, small cell lung cancer, etc.
Methotrexate
Indication: 1. Systemic medication for the treatment of choriocarcinoma, malignant hydatidiform mole, various acute leukemias with breast cancer, lung cancer, head and neck cancer, digestive tract cancer, cervical cancer and malignant lymphoma. 2. Arterial catheter perfusion has a good effect on head and neck cancer and liver cancer. 3. High-dose methotrexate supplemented with calcium folinate rescue (HDMTX-CFR therapy) has a certain effect as postoperative adjuvant chemotherapy or systemic treatment of advanced lesions for osteosarcoma, soft tissue sarcoma, malignant lymphoma, acute lymphocytic leukemia with breast cancer, ovarian cancer, small cell lung cancer, etc.
Manufacturer:

Bei Jing Scrianen Pharmaceutical Co., Ltd.

Methotrexate
Indication: 1. Systemic medication for the treatment of choriocarcinoma, malignant hydatidiform mole, various acute leukemias with breast cancer, lung cancer, head and neck cancer, digestive tract cancer, cervical cancer and malignant lymphoma. 2. Arterial catheter perfusion has a good effect on head and neck cancer and liver cancer. 3. High-dose methotrexate supplemented with calcium folinate rescue (HDMTX-CFR therapy) has a certain effect as postoperative adjuvant chemotherapy or systemic treatment of advanced lesions for osteosarcoma, soft tissue sarcoma, malignant lymphoma, acute lymphocytic leukemia with breast cancer, ovarian cancer, small cell lung cancer, etc.
Manufacturer:

Zhejiang Hisun Pharmaceutical Co., Ltd.

Methotrexate
Indication: 1. Systemic medication for the treatment of choriocarcinoma, malignant hydatidiform mole, various acute leukemias with breast cancer, lung cancer, head and neck cancer, digestive tract cancer, cervical cancer and malignant lymphoma. 2. Arterial catheter perfusion has a good effect on head and neck cancer and liver cancer. 3. High-dose methotrexate supplemented with calcium folinate rescue (HDMTX-CFR therapy) has a certain effect as postoperative adjuvant chemotherapy or systemic treatment of advanced lesions for osteosarcoma, soft tissue sarcoma, malignant lymphoma, acute lymphocytic leukemia with breast cancer, ovarian cancer, small cell lung cancer, etc.
Manufacturer:

Huzhou Zhanwang Pharmaceutical Co., Ltd.

Recombinant human interferon α2b for injection
Indication: It can be used to treat acute and chronic viral hepatitis (type B, type C, etc.), genital warts, hairy cell leukemia, chronic myeloid leukemia, lymphoma, AIDS-related Kaposi's sarcoma, malignant melanoma and other diseases.
Manufacturer:

Anhui Anke Biotechnology (Group) Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.